Should inflammatory pathways be targeted for the prevention and treatment of hypertension?

Setor K. Kunutsor; Jari A. Laukkanen

doi:10.1136/heartjnl-2018-314625

Should inflammatory pathways be targeted for the prevention and treatment of hypertension?

Setor K. Kunutsor, Jari A. Laukkanen^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article (Academic Journal) › peer-review

6 Citations (Scopus)

232 Downloads (Pure)

Abstract

[no abstract]

Original language	English
Pages (from-to)	665-667
Number of pages	3
Journal	Heart
Volume	105
Issue number	9
Early online date	30 Jan 2019
DOIs	https://doi.org/10.1136/heartjnl-2018-314625
Publication status	Published - 1 May 2019

Keywords

epidemiology
hypertension
inflammatory markers
meta-analysis
systemic review

Access to Document

10.1136/heartjnl-2018-314625

Full-text PDF (accepted author manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via BMJ Publishing at https://heart.bmj.com/content/early/2019/01/29/heartjnl-2018-314625 . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 427 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

@article{cc33a3fbe1b1469db393ec67c5002331,

title = "Should inflammatory pathways be targeted for the prevention and treatment of hypertension?",

abstract = "[no abstract]",

keywords = "epidemiology, hypertension, inflammatory markers, meta-analysis, systemic review",

author = "Kunutsor, {Setor K.} and Laukkanen, {Jari A.}",

year = "2019",

month = may,

day = "1",

doi = "10.1136/heartjnl-2018-314625",

language = "English",

volume = "105",

pages = "665--667",

journal = "Heart",

issn = "1355-6037",